Event summary

Wednesday, May 27, 2026
8:30 – 9:30 am PT // 11:30 am – 12:30 pm ET // 4:30 – 5:30 pm BST

Join us for a timely discussion on the evolving US securities class action (SCA) landscape for life sciences companies. Our panel of legal and insurance industry leaders will explore primary causes, key milestones, key developments from 2025 and practical approaches to managing these complex legal challenges.

Panelists

  • Koji Fukumura – Partner, Cooley
  • Sam Hancocks – Senior Claims Examiner, Executive & Professional Liability, Berkshire Hathaway Specialty Insurance UK
  • Tom Harris – Head of Management Liability, Berkshire Hathaway Specialty Insurance UK

Agenda

  • Overview of the life sciences US SCA landscape – Understand why life sciences companies remain prime targets for securities litigation, what to expect if sued, and the timeline and potential costs of a shareholder lawsuit
  • Life sciences SCAs: 2025 year in review – A look back on key statistics, trends and noteworthy cases
  • Regulatory trends and outlook – The regulatory landscape continues to be fast moving; what does this continued regulatory volatility mean for risks related to directors and officers?
  • Minimizing securities fraud litigation risk – Managing disclosure risk in an ever-changing regulatory environment, with practical guidance to best protect your company from securities-related litigation or Securities and Exchange Commission investigations

For more information, please email Ron Page.

Details and registration

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.